Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aztreonam. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.52 |
| ▸ | PGR | P06401 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aztreonam SCHEMBL10674684 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL16863406 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL4469609 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL9424911 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL37512 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL10464547 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL37511 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL26423 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL14209115 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR | |
| Aztreonam SCHEMBL10516547 | 1.00 | ESR1 (1.00) | ESR1USP2KDM4ENR1I2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065038-A1 | New therapeutic approaches for treating Charcot-Marie-Tooth disease | Pharnext (FR) | 2009-06-03 | — | — | EP | claimed |
| EP-2181330-B2 | COMPOSITIONS AND MEANS FOR DIAGNOSING MICROBIAL INFECTIONS | STATENS SERUMINSTITUT (DK) | 2016-08-31 | — | — | EP | disclosed |
| EP-2181330-B1 | COMPOSITIONS AND MEANS FOR DIAGNOSING MICROBIAL INFECTIONS | STATENS SERUMINSTITUT (DK) | 2013-11-20 | — | — | EP | disclosed |
| EP-2065038-A1 | New therapeutic approaches for treating Charcot-Marie-Tooth disease | Pharnext (FR) | 2009-06-03 | — | — | EP | disclosed |
| EP-1622900-A1 | AZTREONAM BETA-POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT | Teva Gyogyszergyar Reszvenytarsasag (HU) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004103999-A1 | AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT | TEVA Gyógyszergyár Részvénytársaság (HU) | 2004-12-02 | — | — | WO | disclosed |
| US-5194604-A | PROCESS AND INTERMEDIATES FOR BETA-LACTAMS HAVING AMINOTHIAZOLE(IMINOOXYACETIC ACID)ACETIC ACID SIDECHAINS | E. R. SQUIBB & SONS, INC. (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0464705-A1 | Process and intermediates for Beta-lactams having aminothiazole (iminooxyacetic acid)acetic acid sidechains | E.R. SQUIBB & SONS, INC. (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0342423-A2 | Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics | E.R. SQUIBB & SONS, INC. (US) | 1989-11-23 | — | — | EP | disclosed |
| EP-0308416-A1 | N-1 SUBSTITUTED SULFONYLAMINOCARBONYL, C-4 SUBSTITUTED MONOBACTAMS | THE UPJOHN COMPANY (US) | 1989-03-29 | — | — | EP | disclosed |
| WO-1987007273-A2 | N-1 SUBSTITUTED SULFONYLAMINOCARBONYL, C-4 SUBSTITUTED MONOBACTAMS | THE UPJOHN COMPANY (US) | 1987-12-03 | — | — | WO | disclosed |